RxDoctor Payments Data

Ellen Dayon, MD

Geriatric Medicine · Seal Beach, CANPI 1043279359

Payments from drug & device makers

$399in general payments, 2019–2025

Across 10 payments — averaging $39.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$119
  • AstraZeneca$119
  • Radius Health, Inc.$32
  • Astellas Pharma US Inc$31
  • Inari Medical, Inc.$30
  • Novartis$21
  • plus $47 from 3 others

What the payments were for

  • Food & beverage$399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$399 in reported general payments places this provider in the 65th percentile of 494 geriatric medicine providers in California.

See all geriatric medicine providers in California

Medicare billing

Part B allowed, 2024
$36,896
Medicare patients
87
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$65,157
JanuviaSitagliptin Phosphate13$18,544
XareltoRivaroxaban16$13,516
Levothyroxine Sodium225$3,368
Atorvastatin Calcium274$2,742
Metoprolol Succinate101$1,994
Losartan Potassium113$1,681
SynthroidLevothyroxine Sodium50$1,270
Lisinopril149$1,248
Omeprazole98$1,152
Potassium Chloride47$1,126
Simvastatin111$988
Gabapentin77$915
Amlodipine Besylate159$837
Felodipine ErFelodipine14$792

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$12$18,54413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 494 geriatric medicine providers in California.

Other geriatric medicine in Seal Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →